olmesartan medoxomil has been researched along with Goldblatt Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, ZC; Wang, JP; Wang, XX; Yu, HY; Zhang, M | 1 |
Fukushima, R; Imai, H; Ishida, Y; Nakamoto, H; Suzuki, H; Yamanouchi, Y | 1 |
Imai, H; Ishida, Y; Nakamoto, H; Suzuki, H; Tomori, K | 1 |
3 other study(ies) available for olmesartan medoxomil and Goldblatt Syndrome
Article | Year |
---|---|
Olmesartan medoxomil reverses left ventricle hypertrophy and reduces inflammatory cytokine IL-6 in the renovascular hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Disease Models, Animal; Down-Regulation; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Imidazoles; Inflammation Mediators; Interleukin-6; Male; Olmesartan Medoxomil; Rats; Rats, Wistar; Tetrazoles; Ultrasonography; Ventricular Remodeling | 2013 |
Role of the renin-angiotensin system in the pathogenesis of peritoneal fibrosis.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Dialysis Solutions; Disease Models, Animal; Disease Progression; Fibrosis; Hydrogen-Ion Concentration; Hypertension, Renovascular; Imidazoles; Male; Olmesartan Medoxomil; Peritoneal Dialysis; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles | 2008 |
Effects of antihypertensive drugs on peritoneal vessels in hypertensive dogs with mild renal insufficiency.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aquaporins; Benzazepines; Blood Pressure; Calcium Channel Blockers; Dogs; Hypertension, Renovascular; Imidazoles; Microcirculation; Olmesartan Medoxomil; Peritoneum; Renal Insufficiency; Tetrazoles; Vasodilation | 2003 |